Non-diabetic Elderly Populations: the MHR As a Protective Factor Against Bone Abnormalities

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Jun 24

PMID 38911035

Authors

Xiang Li

Manli Yan

Jiali Ji

Zhuohao Ma

Affiliations

Soon will be listed here.

Abstract

Objectives: In China, osteoporosis has become a major health concern among elderly population, imposing significant burden on the country's social and economic systems. The monocyte to high-density lipoprotein ratio (MHR) has been currently recommended as a novel marker of inflammation and oxidative stress associated with osteoporosis in type 2 diabetes mellitus (T2DM). However, its reliability in non-diabetic elderly populations remains unclear. The present study was to evaluate the association between MHR and osteoporosis in a non-diabetic elderly population.

Methods: The clinical data of 240 non-diabetic elderly subjects (115 in the osteoporosis group and 125 in the normal bone group) were retrospectively analyzed and all statistical analyses were performed by using SPSS 26.0.

Results: Differences in age, neutrophils, lymphocytes, monocytes, MHR, uric acid, creatinine, triglycerides,and high-density lipoprotein cholesterol were found to be statistically significant between the two groups. A binary logistic regression model was conducted by including age, MHR, UA and Cr as variables. The results showed that age was an independent risk factor and MHR was an independent protective factor for bone abnormality in the non-diabetic elderly population. The ROC analysis showed that the area under the curve for the predictive effect of MHR, age and their combined test on osteoporosis in non-diabetic elderly populations was 0.623, 0.728 and 0.761, respectively; the correlation analysis showed that MHR was positively correlated with lumbar and hip BMD, and negatively associated with femoral neck stress ratio, femoral intertrochanteric stress ratio, and femoral stem stress ratio, showing statistically significant differences (P<0.05).

Conclusions: For the non-diabetic elderly population: the MHR is a protective factor against bone abnormalities and was significantly higher in the normal bone group than in the abnormal bone group.

Citing Articles

Relationship of monocyte to high-density lipoprotein ratio (MHR) and other inflammatory biomarkers with sarcopenia: a population-based study.

Xue Z, Cao J, Mou J, Wang R, Liu P Lipids Health Dis. 2025; 24(1):42.

PMID: 39923040 PMC: 11806851. DOI: 10.1186/s12944-025-02464-2.

References

Huang R, Chen Y, Tu M, Wang W . Monocyte to high-density lipoprotein and apolipoprotein A1 ratios are associated with bone homeostasis imbalance caused by chronic inflammation in postmenopausal women with type 2 diabetes mellitus. Front Pharmacol. 2022; 13:1062999. PMC: 9676449. DOI: 10.3389/fphar.2022.1062999. View

Zhou F, Wu L, Shen G, Chen X, Liu C, Huang D . Association between monocyte to high-density lipoprotein-cholesterol ratio and osteoporosis: An analysis of the National Health and Nutrition Examination Survey 2013-2014. J Investig Med. 2023; 72(1):3-12. DOI: 10.1177/10815589231204057. View

Yang L, He C, Wang W . Association between neutrophil to high-density lipoprotein cholesterol ratio and disease severity in patients with acute biliary pancreatitis. Ann Med. 2024; 56(1):2315225. PMC: 10860409. DOI: 10.1080/07853890.2024.2315225. View

Murphy A, Woollard K, Hoang A, Mukhamedova N, Stirzaker R, McCormick S . High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 2008; 28(11):2071-7. DOI: 10.1161/ATVBAHA.108.168690. View

Zhang P, Chen H, Xie B, Zhao W, Shang Q, He J . Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients. Front Endocrinol (Lausanne). 2023; 14:990078. PMC: 10031099. DOI: 10.3389/fendo.2023.990078. View

Liu P, Gao Y, Luo P, Yu H, Guo S, Liu F . Glucocorticoid-induced expansion of classical monocytes contributes to bone loss. Exp Mol Med. 2022; 54(6):765-776. PMC: 9256622. DOI: 10.1038/s12276-022-00764-6. View

Sun Y, Qi X, Wang X, Lin X, Zhou Y, Du Y . Association between high-density lipoprotein cholesterol and lumbar bone mineral density in Chinese: a large cross-sectional study. Lipids Health Dis. 2024; 23(1):27. PMC: 10807139. DOI: 10.1186/s12944-024-02023-1. View

Su Y, Chen C, Tsai N, Huang C, Wang H, Kung C . The Role of Monocyte Percentage in Osteoporosis in Male Rheumatic Diseases. Am J Mens Health. 2017; 11(6):1772-1780. PMC: 5675259. DOI: 10.1177/1557988317721642. View

Dule S, Barchetta I, Cimini F, Passarella G, Dellanno A, Filardi T . Reduced High-Density Lipoprotein Cholesterol Is an Independent Determinant of Altered Bone Quality in Women with Type 2 Diabetes. Int J Mol Sci. 2023; 24(7). PMC: 10095189. DOI: 10.3390/ijms24076474. View

10.

Hussain S, Ebeling P, Barker A, Beilin L, Tonkin A, McNeil J . Association of Plasma High-Density Lipoprotein Cholesterol Level With Risk of Fractures in Healthy Older Adults. JAMA Cardiol. 2023; 8(3):268-272. PMC: 9857824. DOI: 10.1001/jamacardio.2022.5124. View

11.

Lu Y, Gu L, Jiang Y . Positive association of fasting plasma glucose with bone mineral density in non-diabetic elderly females. J Bone Miner Metab. 2022; 40(5):755-762. DOI: 10.1007/s00774-022-01341-7. View

12.

Yurtdas M, Yaylali Y, Ozdemir M . The role of monocyte to HDL ratio in predicting clinically significant carotid stenosis in patients with asymptomatic carotid artery disease. Rev Assoc Med Bras (1992). 2020; 66(8):1043-1048. DOI: 10.1590/1806-9282.66.8.1043. View

13.

Wu D, Zhu G, Zhao K, Gao J, Cai G, Li H . Age-related decline in melatonin contributes to enhanced osteoclastogenesis via disruption of redox homeostasis. Mol Med. 2024; 30(1):10. PMC: 10785421. DOI: 10.1186/s10020-024-00779-x. View

14.

Wang P, Zhang Y, Shan R, Wu J, Man S, Deng Y . Association between trajectories of fasting plasma glucose and risk of osteoporosis in non-diabetic and diabetic populations. Front Public Health. 2022; 10:960928. PMC: 9679646. DOI: 10.3389/fpubh.2022.960928. View

15.

Gu L, Lai X, Wang Y, Zhang J, Liu J . A community-based study of the relationship between calcaneal bone mineral density and systemic parameters of blood glucose and lipids. Medicine (Baltimore). 2019; 98(27):e16096. PMC: 6635260. DOI: 10.1097/MD.0000000000016096. View

16.

Park J, Kim D, Kim B, Park K, Park D, Hwang Y . Effect of cholesterol variability on the incidence of cataract, dementia, and osteoporosis: A study using a common data model. Medicine (Baltimore). 2023; 102(41):e35548. PMC: 10578724. DOI: 10.1097/MD.0000000000035548. View

17.

DAmelio P, Grimaldi A, Pescarmona G, Tamone C, Roato I, Isaia G . Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis. FASEB J. 2004; 19(3):410-2. DOI: 10.1096/fj.04-2214fje. View

18.

Kilic N, Tasci G, Yilmaz S, Oner P, Korkmaz S . Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia. J Pers Med. 2023; 13(2). PMC: 9958934. DOI: 10.3390/jpm13020276. View

19.

Cao Z, Xue Y, Wang J . Screening diagnostic markers of osteoporosis based on ferroptosis of osteoblast and osteoclast. Aging (Albany NY). 2023; 15(18):9391-9407. PMC: 10564410. DOI: 10.18632/aging.204945. View

20.

Gomaraschi M, Basilico N, Sisto F, Taramelli D, Eligini S, Colli S . High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli. Biochim Biophys Acta. 2005; 1736(2):136-43. DOI: 10.1016/j.bbalip.2005.08.003. View